Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase

Heterocycles are the key structures in organic chemistry owing to their immense applications in the biological, chemical, and pharmaceutical fields. Heterocyclic compounds perform various noteworthy functions in nature, medication, innovation etc. Most frequently, pure nitrogen heterocycles or various positional combinations of nitrogen, oxygen, and sulfur atoms in five or six-membered rings can be found. Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes is a popular strategy for the management of numerous mental diseases. In this context, cholinesterase inhibitors are utilized to relieve the symptoms of neurological illnesses like dementia and Alzheimer's disease (AD). The present review focuses on various heterocyclic scaffolds and their role in designing and developing new potential AChE and BChE inhibitors to treat AD. Moreover, a detailed structure–activity relationship (SAR) has been established for the future discovery of novel drugs for the treatment of AD. Most of the heterocyclic motifs have been used in the design of new potent cholinesterase inhibitors. In this regard, this review is an endeavor to summarize the biological and chemical studies over the past decade (2010–2022) describing the pursuit of new N, O and S containing heterocycles which can offer a rich supply of promising AChE and BChE inhibitory activities.

[1]  A. Kamal,et al.  Novel linezolid-based oxazolidinones as potent anticandidiasis and antitubercular agents. , 2022, Bioorganic chemistry.

[2]  Safeer Ahmed,et al.  Chalcone- and flavone-based novel terpyridine metal complexes: Synthesis, electrochemical, photophysical, photovoltaic and computational studies , 2022, Dyes and Pigments.

[3]  S. Adil,et al.  Multicomponent synthesis, cytotoxicity, and computational studies of novel imidazopyridazine-based N-phenylbenzamides , 2022, Journal of Saudi Chemical Society.

[4]  Reem I. Alsantali,et al.  Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies , 2022, ACS omega.

[5]  Z. Abduljaleel,et al.  New Imidazole-Based N-Phenylbenzamide Derivatives as Potential Anticancer Agents: Key Computational Insights , 2022, Frontiers in Chemistry.

[6]  M. Ansari,et al.  Bioactive fluorenes. Part IV: Design, synthesis, and a combined in vitro, in silico anticancer and antibacterial evaluation of new fluorene-heterocyclic sulfonamide conjugates , 2021 .

[7]  Mubashir Hassan,et al.  Synthesis, kinetics and biological assay of some novel aryl bis-thioureas: A potential drug candidates for Alzheimer's disease , 2021 .

[8]  S. Chander,et al.  Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation. , 2021, Bioorganic chemistry.

[9]  Saleh A. Ahmed,et al.  Miscellaneous azo dyes: A comprehensive review on recent advancements in biological and industrial Applications , 2021, Dyes and Pigments.

[10]  Saleh A. Ahmed,et al.  Flavone-based Hydrazones as New Tyrosinase Inhibitors: Synthetic Imines with Emerging Biological Potential, SAR, Molecular Docking and Drug-likeness Studies , 2021, Journal of Molecular Structure.

[11]  Saleh A. Ahmed,et al.  Ionic liquid mediated four-component synthesis of novel phthalazinone based indole-pyran hybrids as cytotoxic agents , 2021, Arabian Journal of Chemistry.

[12]  H. Alsaab,et al.  Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis , 2021, Molecules.

[13]  Hybrids of Thiazolidin-4-Ones and 1,3,4-Thiadiazole: Synthesis and Biological Screening of A Potential New Class of Acetylcholinesterae Inhibitors , 2021, Biointerface Research in Applied Chemistry.

[14]  T. Nualnoi,et al.  Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold , 2021, Molecules.

[15]  Burak Barut,et al.  Azole antifungal compounds could have dual cholinesterase inhibitory potential according to virtual screening, enzyme kinetics, and toxicity studies of an inhouse library , 2021, Journal of Molecular Structure.

[16]  Y. Şirin,et al.  Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: A review. , 2021, Bioorganic chemistry.

[17]  Vipan Kumar,et al.  1H-1,2,3-triazole grafted tacrine-chalcone conjugates as potential cholinesterase inhibitors with the evaluation of their behavioral tests and oxidative stress in mice brain cells. , 2021, Bioorganic chemistry.

[18]  Saleh A. Ahmed,et al.  Novel Pyran-Linked Phthalazinone-Pyrazole Hybrids: Synthesis, Cytotoxicity Evaluation, Molecular Modeling, and Descriptor Studies , 2021, Frontiers in Chemistry.

[19]  Timothy J. Hohman,et al.  Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions , 2021, Molecular Neurodegeneration.

[20]  Ankit Seth,et al.  Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease. , 2021, Bioorganic chemistry.

[21]  O. Firuzi,et al.  Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents , 2021 .

[22]  M. Ansari,et al.  Rational Design and Synthesis of Naphthalene Diimide Linked Bis-Naphthalimides as DNA Interactive Agents , 2021, Frontiers in Chemistry.

[23]  Anil Kumar Garige,et al.  Design and Friedlander Reaction Based Synthesis of New Cycloalkyl Ring Fused Quinolines as Multifunctional Agents for Alzheimer's Treatment: In Silico Studies , 2021 .

[24]  M. Zafar,et al.  Structure-based designing and synthesis of 2-phenylchromone derivatives as potent tyrosinase inhibitors: In vitro and in silico studies. , 2021, Bioorganic & medicinal chemistry.

[25]  S. Prajapati,et al.  Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation. , 2021, European journal of medicinal chemistry.

[26]  S. Awan,et al.  Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach , 2021, Molecules.

[27]  Swati S. More,et al.  Sulfur-containing therapeutics in the treatment of Alzheimer’s disease , 2021, Medicinal Chemistry Research.

[28]  Anil Kumar Garige,et al.  Molecular hybridization based design and synthesis of new benzo[5,6]chromeno[2,3-b]-quinolin-13(14H)-one analogs as cholinesterase inhibitors , 2021, Medicinal Chemistry Research.

[29]  M. Zafar,et al.  New organosulfur metallic compounds as potent drugs: synthesis, molecular modeling, spectral, antimicrobial, drug likeness and DFT analysis , 2021, Molecular Diversity.

[30]  M. Bajda,et al.  Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors. , 2021, Bioorganic chemistry.

[31]  N. Askari,et al.  Design, synthesis and biological assessment of acridine derivatives containing 1,3,4-thiadiazole moiety as novel selective acetylcholinesterase inhibitors. , 2020, Bioorganic chemistry.

[32]  A. Belfaitah,et al.  Design, synthesis, biological evaluation, molecular docking, DFT calculations and in silico ADME analysis of (benz)imidazole-hydrazone derivatives as promising antioxidant, antifungal, and anti-acetylcholinesterase agents , 2020, Journal of Molecular Structure.

[33]  S. Muhammad,et al.  Design and synthesis of new flavonols as dual ɑ-amylase and ɑ-glucosidase inhibitors: Structure-activity relationship, drug-likeness, in vitro and in silico studies , 2020 .

[34]  Yeliz Demir,et al.  Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors. , 2020, International journal of biological macromolecules.

[35]  Aziz‐ur‐Rehman,et al.  Synthesis and Structure-Activity Relationship of 1-(2-Furoyl)Piperazine Bearing Benzamides as Butyrylcholinesterase Inhibitors , 2020, Pharmaceutical Chemistry Journal.

[36]  K. Thai,et al.  Synthesis, In Silico and In Vitro Evaluation for Acetylcholinesterase and BACE-1 Inhibitory Activity of Some N-Substituted-4-Phenothiazine-Chalcones , 2020, Molecules.

[37]  I. Gulcin,et al.  Design, synthesis, characterization, biological evaluation, and molecular docking studies of novel 1,2-aminopropanthiols substituted derivatives as selective carbonic anhydrase, acetylcholinesterase and α-glycosidase enzymes inhibitors , 2020, Journal of biomolecular structure & dynamics.

[38]  Ya-Fang Chen,et al.  Design and synthesis of 7-diethylaminocoumarin-based 1,3,4-oxadiazole derivatives with anti-acetylcholinesterase activities , 2020, Journal of Asian natural products research.

[39]  P. Piplani,et al.  Design, synthesis and biological evaluation of triazole-oxadiazole conjugates for the management of cognitive dysfunction. , 2020, Bioorganic chemistry.

[40]  M. Mirzaei,et al.  Exploring 3-hydroxyflavone scaffolds as mushroom tyrosinase inhibitors: synthesis, X-ray crystallography, antimicrobial, fluorescence behaviour, structure-activity relationship and molecular modelling studies , 2020, Journal of biomolecular structure & dynamics.

[41]  P. Kaur,et al.  New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation. , 2020, Bioorganic & medicinal chemistry letters.

[42]  M. Zafar,et al.  Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure–activity relationship and molecular modelling simulations , 2020, Journal of biomolecular structure & dynamics.

[43]  Xing Feng,et al.  Nitrogen‐containing flavonoid and their analogs with diverse B‐ring in acetylcholinesterase and butyrylcholinesterase inhibition , 2020, Drug development research.

[44]  Ahmed E. M. Mekky,et al.  Novel nicotinonitrile-coumarin hybrids as potential acetylcholinesterase inhibitors: design, synthesis, in vitro and in silico studies , 2020, Journal of the Iranian Chemical Society.

[45]  J. Parkash,et al.  Design, Synthesis and Evaluation of O ‐Pentyne Substituted Diphenylpyrimidines as Monoamine Oxidase and Acetylcholinesterase Inhibitors , 2020 .

[46]  H. Pham-The,et al.  Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease. , 2020, Bioorganic & medicinal chemistry letters.

[47]  L. Dardenne,et al.  Design, Synthesis and Biological Evaluation of Novel Triazole N-acylhydrazone Hybrids for Alzheimer’s Disease , 2020, Molecules.

[48]  Avanish Tripathi,et al.  Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer’s disease , 2020, Journal of Computer-Aided Molecular Design.

[49]  Saleh A. Ahmed,et al.  Tailoring of novel biologically active molecules based on N-substituted sulfonamides bearing thiazole moiety exhibiting unique multi-addressable biological potentials , 2020 .

[50]  Kranthi Kumar Gangu,et al.  A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications , 2020, Molecules.

[51]  M. Ramana,et al.  Design, synthesis and evaluation of new chromone-derived aminophosphonates as potential acetylcholinesterase inhibitor , 2020, Molecular Diversity.

[52]  2020 Alzheimer's disease facts and figures , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[53]  Rafik Bensegueni,et al.  Synthesis, antioxidant and anticholinesterase activities of novel quinoline‐aminophosphonate derivatives , 2020 .

[54]  I. Gulcin,et al.  Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes. , 2020, Bioorganic chemistry.

[55]  T. Nualnoi,et al.  Synthesis and evaluation of chromone-2-carboxamido-alkylamines as potent acetylcholinesterase inhibitors , 2020, Medicinal Chemistry Research.

[56]  M. Ramana,et al.  Design, synthesis and evaluation of pyrazole bearing α-aminophosphonate derivatives as potential acetylcholinesterase inhibitors against Alzheimer's disease. , 2020, Bioorganic chemistry.

[57]  Shahrzad Javanshir,et al.  Magnetic γFe2O3@Sh@Cu2O: an efficient solid-phase catalyst for reducing agent and base-free click synthesis of 1,4-disubstituted-1,2,3-triazoles , 2020, BMC chemistry.

[58]  C. Supuran,et al.  Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile , 2020, Journal of enzyme inhibition and medicinal chemistry.

[59]  C. Solcan,et al.  Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement , 2019, Biomolecules.

[60]  S. N. Bukhari,et al.  Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors , 2019, Molecular Diversity.

[61]  Piyoosh Sharma,et al.  Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease. , 2019, Bioorganic chemistry.

[62]  M. Safavi,et al.  Design, synthesis, and in vitro evaluation of novel 1,3,4-oxadiazolecarbamothioate derivatives of Rivastigmine as selective inhibitors of BuChE , 2019, Medicinal Chemistry Research.

[63]  Q. Guo,et al.  Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors. , 2019, Bioorganic chemistry.

[64]  S. Prajapati,et al.  Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease. , 2019, European journal of medicinal chemistry.

[65]  A. Almansour,et al.  Design, synthesis and cholinesterase inhibitory activity of novel spiropyrrolidine tethered imidazole heterocyclic hybrids. , 2019, Bioorganic & medicinal chemistry letters.

[66]  Wenjian Tang,et al.  Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies. , 2019, European journal of medicinal chemistry.

[67]  I. Gulcin,et al.  Pyrazole[3,4-d]pyridazine derivatives: Molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials. , 2019, Bioorganic chemistry.

[68]  K. Rakesh,et al.  Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships. , 2019, European journal of medicinal chemistry.

[69]  M. Zafar,et al.  Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies. , 2019, Bioorganic chemistry.

[70]  Piyoosh Sharma,et al.  Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer's Disease. , 2019, ACS chemical neuroscience.

[71]  Z. Şahin,et al.  Novel thiazole‐piperazine derivatives as potential cholinesterase inhibitors , 2019, Journal of Heterocyclic Chemistry.

[72]  A. Saeed,et al.  Investigation of potent inhibitors of cholinesterase based on thiourea and pyrazoline derivatives: Synthesis, inhibition assay and molecular modeling studies. , 2019, Bioorganic chemistry.

[73]  V. Kouznetsov,et al.  Synthesis, Biological Evaluation and in silico Computational Studies of 7-Chloro-4-(1H-1,2,3-triazol-1-yl)quinoline Derivatives. Search for new controlling agents against Spodoptera frugiperda (Lepidoptera: Noctuidae) larvae. , 2019, Journal of agricultural and food chemistry.

[74]  M. C. Barreto,et al.  Fatty acid composition, TLC screening, ATR-FTIR analysis, anti-cholinesterase activity, and in vitro cytotoxicity to A549 tumor cell line of extracts of 3 macroalgae collected in Madeira , 2019, Journal of Applied Phycology.

[75]  D. Dickson,et al.  The neuropathological diagnosis of Alzheimer’s disease , 2019, Molecular Neurodegeneration.

[76]  Puja Mishra,et al.  Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions. , 2019, Bioorganic chemistry.

[77]  J. D. Figueroa-Villar,et al.  Synthesis of New Quinoline-Piperonal Hybrids as Potential Drugs against Alzheimer’s Disease , 2019, International journal of molecular sciences.

[78]  O. Firuzi,et al.  5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer’s disease modifying agents , 2019, Molecular Diversity.

[79]  Zhi Xu,et al.  1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents. , 2019, European journal of medicinal chemistry.

[80]  Saleh A. Ahmed,et al.  Design, synthesis, and biological evaluation of novel N4-substituted sulfonamides: acetamides derivatives as dihydrofolate reductase (DHFR) inhibitors , 2019, BMC Chemistry.

[81]  Amisha,et al.  Overview of artificial intelligence in medicine , 2019, Journal of family medicine and primary care.

[82]  A. Foroumadi,et al.  Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti‐Alzheimer's agents , 2019, Archiv der Pharmazie.

[83]  Ashok Kumar,et al.  Development of pyrazole and spiropyrazoline analogs as multifunctional agents for treatment of Alzheimer's disease. , 2019, Bioorganic chemistry.

[84]  I. Gulcin,et al.  Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives , 2019, Archiv der Pharmazie.

[85]  Keun Woo Lee,et al.  Tryptamine–Triazole Hybrid Compounds for Selective Butyrylcholinesterase Inhibition , 2019, Bulletin of the Korean Chemical Society.

[86]  Suleyman Akocak,et al.  Design, synthesis and biological evaluation of 1,3-diaryltriazene-substituted sulfonamides as antioxidant, acetylcholinesterase and butyrylcholinesterase inhibitors , 2019, Journal of the Turkish Chemical Society, Section A: Chemistry.

[87]  Jagadish Singh,et al.  Acute Rat and Mouse Oral Toxicity Determination of Anticholinesterase Inhibitor Carbamate Pesticides: A QSTR Approach , 2019, Molecular informatics.

[88]  U. Rashid,et al.  Differential functional theory and molecular docking studies of newly synthesized carbamates , 2019, Journal of the Chinese Chemical Society.

[89]  M. Şentürk,et al.  Synthesis of 5-methyl-2,4-dihydro-3H-1,2,4-triazole-3-one's aryl Schiff base derivatives and investigation of carbonic anhydrase and cholinesterase (AChE, BuChE) inhibitory properties. , 2019, Bioorganic chemistry.

[90]  P. Taslimi,et al.  Mono- or di-substituted imidazole derivatives for inhibition of acetylcholine and butyrylcholine esterases. , 2019, Bioorganic chemistry.

[91]  S. Rai,et al.  Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. , 2019, Bioorganic chemistry.

[92]  Aladdin M. Srour,et al.  Synthesis and 2D-QSAR study of dispiropyrrolodinyl-oxindole based alkaloids as cholinesterase inhibitors. , 2019, Bioorganic chemistry.

[93]  B. Larijani,et al.  Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives. , 2019, Bioorganic chemistry.

[94]  M. Sharifzadeh,et al.  Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study. , 2019, Bioorganic chemistry.

[95]  H. El‐Seedi,et al.  Drug-1,3,4-Thiadiazole Conjugates as Novel Mixed-Type Inhibitors of Acetylcholinesterase: Synthesis, Molecular Docking, Pharmacokinetics, and ADMET Evaluation , 2019, Molecules.

[96]  Piyoosh Sharma,et al.  Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions. , 2019, Bioorganic & medicinal chemistry.

[97]  S. Shankar,et al.  Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory. , 2019, European journal of medicinal chemistry.

[98]  O. Firuzi,et al.  Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole‐Phenylpiperazine Derivatives , 2019, Chemistry & biodiversity.

[99]  F. Feng,et al.  Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. , 2018, European journal of medicinal chemistry.

[100]  I. Gulcin,et al.  Some pyrazoles derivatives: Potent carbonic anhydrase, α‐glycosidase, and cholinesterase enzymes inhibitors , 2018, Archiv der Pharmazie.

[101]  Jamshed Iqbal,et al.  Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies , 2018, Comput. Biol. Chem..

[102]  M. Bajda,et al.  Novel carbamate derivatives as selective butyrylcholinesterase inhibitors. , 2018, Bioorganic chemistry.

[103]  Manzoor Ahmad,et al.  Norditerpenoid alkaloids of Delphinium denudatum as cholinesterase inhibitors. , 2018, Bioorganic chemistry.

[104]  B. Korkut,et al.  Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease , 2018, Molecules.

[105]  D. Yan,et al.  2-Substituted-1-(2-morpholinoethyl)-1H-naphtho[2,3-d]imidazole-4,9-diones: Design, synthesis and antiproliferative activity. , 2018, Bioorganic & medicinal chemistry letters.

[106]  J. T. Njardarson,et al.  From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles. , 2018, Journal of medicinal chemistry.

[107]  S. N. Bukhari,et al.  Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities. , 2018, European journal of medicinal chemistry.

[108]  M. Zafar,et al.  Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors. , 2018, Bioorganic & medicinal chemistry.

[109]  S. Sinha,et al.  Design, Synthesis and Evaluation of 4-Aminopyridine Analogues as Cholinesterase Inhibitors for Management of Alzheimer’s Diseases , 2018, Indian Journal of Pharmaceutical Education and Research.

[110]  M. Kamal,et al.  Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[111]  U. Farooq,et al.  Combined in Vitro and in Silico Studies for the Anticholinesterase Activity and Pharmacokinetics of Coumarinyl Thiazoles and Oxadiazoles , 2018, Front. Chem..

[112]  Ozden Tacal,et al.  Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease. , 2018, Biochimie.

[113]  Suzan M. Abuel-Maaty,et al.  Synthesis and biological evaluation of new oxopyrrolidine derivatives as inhibitors of acetyl cholinesterase and β amyloid protein as anti - Alzheimer's agents. , 2018, Bioorganic chemistry.

[114]  J. Iqbal,et al.  Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition. , 2018, Medicinal chemistry (Shariqah (United Arab Emirates)).

[115]  Mahboob Alam,et al.  Synthesis, spectroscopic, computational (DFT/B3LYP), AChE inhibition and antioxidant studies of imidazole derivative , 2018 .

[116]  P. Taslimi,et al.  Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles , 2018, Archives of physiology and biochemistry.

[117]  I. Gulcin,et al.  Synthesis of some novel pyridine compounds containing bis‐1,2,4‐triazole/thiosemicarbazide moiety and investigation of their antioxidant properties, carbonic anhydrase, and acetylcholinesterase enzymes inhibition profiles , 2018, Journal of biochemical and molecular toxicology.

[118]  S. Rasool,et al.  Synthesis of new heterocyclic 3-piperidinyl-1,3,4-oxadiazole derivatives as potential drug candidate for the treatment of Alzheimer’s disease , 2018 .

[119]  J. Iqbal,et al.  Compounds with 1,3,4-oxadiazole and azinane appendages to evaluate enzymes inhibition applications supported by docking and BSA binding , 2018 .

[120]  A. Almansour,et al.  Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines. , 2017, Bioorganic chemistry.

[121]  V. Andrisano,et al.  New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation. , 2017, European journal of medicinal chemistry.

[122]  Mihaela-Liliana Ţînţaş,et al.  Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation. , 2017, Journal of medicinal chemistry.

[123]  Wenmin Liu,et al.  Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. , 2017, Bioorganic & medicinal chemistry.

[124]  U. Rashid,et al.  Synthesis, crystal structure determination, biological screening and docking studies of N1-substituted derivatives of 2,3-dihydroquinazolin-4(1H)-one as inhibitors of cholinesterases. , 2017, Bioorganic chemistry.

[125]  Haopeng Sun,et al.  Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease. , 2017, European journal of medicinal chemistry.

[126]  M. Yar,et al.  An Efficient Synthesis of bi‐Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease , 2017, Archiv der Pharmazie.

[127]  Kapil Kumar,et al.  Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review , 2017, European Journal of Medicinal Chemistry.

[128]  A. Foroumadi,et al.  New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates. , 2017, European journal of medicinal chemistry.

[129]  T. Mohamed,et al.  2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies. , 2017, European journal of medicinal chemistry.

[130]  B. Malawska,et al.  Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy. , 2017, European journal of medicinal chemistry.

[131]  Syed Umar Farooq Rizvi,et al.  Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones. , 2017, Biochemical and biophysical research communications.

[132]  Yung-Hyun Choi,et al.  α-Isocubebenol alleviates scopolamine-induced cognitive impairment by repressing acetylcholinesterase activity , 2017, Neuroscience Letters.

[133]  M. Sharifzadeh,et al.  Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors. , 2017, European journal of medicinal chemistry.

[134]  U. Rashid,et al.  Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors. , 2016, Bioorganic chemistry.

[135]  S. Tzartos,et al.  The role of carbohydrate component of recombinant α7 nicotinic acetylcholine receptor extracellular domain in its immunogenicity and functional effects of resulting antibodies. , 2016, Immunobiology.

[136]  Yusuf Sıcak,et al.  New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors. , 2016, European journal of medicinal chemistry.

[137]  D. Pathak,et al.  Comprehensive review on current developments of quinoline-based anticancer agents , 2016 .

[138]  M. Ananth,et al.  Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline , 2016, Neuron.

[139]  Ayse H. Tarikogullari,et al.  Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors. , 2016, Chemical & pharmaceutical bulletin.

[140]  Luis Alexandre Muehlmann,et al.  Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity. , 2016, Bioorganic & medicinal chemistry letters.

[141]  H. Temel,et al.  Synthesis and Biological Evaluation of Novel Piperazine Containing Hydrazone Derivatives , 2016 .

[142]  A. Shafiee,et al.  Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids. , 2016, Bioorganic chemistry.

[143]  L. Teh,et al.  Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies. , 2016, Bioorganic chemistry.

[144]  A. T. Caldeira,et al.  Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): Molecular docking and saturation transfer difference NMR (STD-NMR). , 2016, Bioorganic chemistry.

[145]  M. Parat,et al.  Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening. , 2016, Journal of medicinal chemistry.

[146]  B. Jayaram,et al.  Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents. , 2016, Bioorganic & medicinal chemistry.

[147]  Jeong Ho Park,et al.  Synthesis and in vitro Assay of New Triazole Linked Decursinol Derivatives Showing Inhibitory Activity against Cholinesterase for Alzheimer’s Disease Therapeutics , 2016 .

[148]  D. Holtzman,et al.  TREM2 Function in Alzheimer's Disease and Neurodegeneration. , 2016, ACS chemical neuroscience.

[149]  I. Carvalho,et al.  Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors , 2016, Molecules.

[150]  L. Chou,et al.  An empirical analysis of land property lawsuits and rainfalls , 2016, SpringerPlus.

[151]  A. Shafiee,et al.  Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone‐1,2,4‐oxadiazole‐1,2,3‐triazole Hybrids , 2015, Chemical biology & drug design.

[152]  Mehr-un-Nisa,et al.  Synthesis of novel triazoles and a tetrazole of escitalopram as cholinesterase inhibitors. , 2015, Bioorganic & medicinal chemistry.

[153]  K. Roy,et al.  In vitro evaluation and in silico screening of synthetic acetylcholinesterase inhibitors bearing functionalized piperidine pharmacophores. , 2015, Bioorganic & medicinal chemistry.

[154]  S. Sathaye,et al.  Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice , 2015, Pharmacology Biochemistry and Behavior.

[155]  N. Coquelle,et al.  Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents. , 2015, Bioorganic & medicinal chemistry.

[156]  P. Piplani,et al.  Design and synthesis of newer potential 4-(N-acetylamino)phenol derived piperazine derivatives as potential cognition enhancers. , 2015, Bioorganic chemistry.

[157]  A. Shafiee,et al.  Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives. , 2015, European journal of medicinal chemistry.

[158]  M. Tiwari,et al.  Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease. , 2015, Bioorganic & medicinal chemistry.

[159]  A. Almansour,et al.  A Facile Ionic Liquid Promoted Synthesis, Cholinesterase Inhibitory Activity and Molecular Modeling Study of Novel Highly Functionalized Spiropyrrolidines , 2015, Molecules.

[160]  J. T. Njardarson,et al.  Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. , 2014, Journal of medicinal chemistry.

[161]  S. Turk,et al.  Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. , 2014, Journal of medicinal chemistry.

[162]  S. Böhm,et al.  Novel tacrine/acridine anticholinesterase inhibitors with piperazine and thiourea linkers. , 2014, International journal of biological macromolecules.

[163]  J. Maessen,et al.  Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor. , 2014, Journal of autoimmunity.

[164]  A. Rehman,et al.  Synthesis, biological evaluation, and molecular docking of N'-(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives , 2014 .

[165]  J. Simpson,et al.  Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. , 2014, European journal of medicinal chemistry.

[166]  A. Allan,et al.  The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review , 2014, Current Environmental Health Reports.

[167]  C. Shishoo,et al.  The chemistry and biological potential of azetidin-2-ones. , 2014, European journal of medicinal chemistry.

[168]  Ling Zhang,et al.  Comprehensive Review in Current Developments of Imidazole‐Based Medicinal Chemistry , 2014, Medicinal research reviews.

[169]  G. N. Sastry,et al.  Synthesis, biological evaluation, and molecular modeling of (E)-2-aryl-5-styryl-1,3,4-oxadiazole derivatives as acetylcholine esterase inhibitors , 2013, Medicinal Chemistry Research.

[170]  L. Yurttaş,et al.  Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors , 2013, Journal of enzyme inhibition and medicinal chemistry.

[171]  V. Murugaiyah,et al.  Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors. , 2013, Bioorganic chemistry.

[172]  M. Karpińska,et al.  Synthesis and anticholinesterase activities of novel 1,3,4-thiadiazole based compounds , 2013, Journal of enzyme inhibition and medicinal chemistry.

[173]  Paweł Szymański,et al.  Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors. , 2013, European journal of medicinal chemistry.

[174]  G. Çiftçi,et al.  Synthesis and Biological Evaluation of Some Pyrazoline Derivatives Bearing a Dithiocarbamate Moiety as New Cholinesterase Inhibitors , 2013, Archiv der Pharmazie.

[175]  Baldev Singh,et al.  A review on cholinesterase inhibitors for Alzheimer’s disease , 2013, Archives of pharmacal research.

[176]  M. Rafiq,et al.  Synthesis and Biological Activities of Some New 3,6-Disubstituted 1,2,4-Triazolo(3,4-b)1,3,4-thiadiazole Derivatives , 2012 .

[177]  M. Eacott,et al.  Citation for Published Item: Use Policy a Specific Role for Septohippocampal Acetylcholine in Memory? , 2022 .

[178]  M. Bajda,et al.  Synthesis and Biological Activity of New 2,3-dihydro-1H-cyclopenta[b]- quinoline Derivatives as Acetylcholinesterase Inhibitors , 2012 .

[179]  O. Sulaiman,et al.  Synthesis, Antimicrobial and Cholinesterase Enzymes Inhibitory Activities of Indeno Imidazoles and X-Ray Crystal Structure of 3a,8a-Dihydroxy-1,3-diphenyl-1,3,3a,8a-tetrahydro-indeno[1,2-d]imidazole-2,8-dione , 2012, Journal of Chemical Crystallography.

[180]  Thierry Noguer,et al.  Acetylcholinesterase Immobilized on Magnetic Beads for Pesticides Detection: Application to Olive Oil Analysis , 2012, Sensors.

[181]  J. Kulisevsky,et al.  Cognitive impairment and dementia in Parkinson's disease , 2012, Neurobiology of Disease.

[182]  A. Gomtsyan,et al.  Heterocycles in drugs and drug discovery , 2012, Chemistry of Heterocyclic Compounds.

[183]  A. Katritzky,et al.  Heterocycles in Life and Society: An Introduction to Heterocyclic Chemistry, Biochemistry and Applications , 2011 .

[184]  S. Ley,et al.  An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals , 2011, Beilstein journal of organic chemistry.

[185]  Jerry Yang,et al.  Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors. , 2011, Bioorganic & medicinal chemistry.

[186]  A. Palmer,et al.  Neuroprotective therapeutics for Alzheimer's disease: progress and prospects. , 2011, Trends in pharmacological sciences.

[187]  Nicholas A. McGrath,et al.  A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives , 2010 .

[188]  E. Banoglu,et al.  Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors. , 2010, Bioorganic & medicinal chemistry.

[189]  M. Valko,et al.  Metals, oxidative stress and neurodegenerative disorders , 2010, Molecular and Cellular Biochemistry.

[190]  V. Holland,et al.  Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor. , 2010, Journal of medicinal chemistry.

[191]  C. Casanova,et al.  Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors , 2010, Cell Death and Disease.

[192]  K. Rangappa,et al.  Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase. , 2009, European journal of medicinal chemistry.

[193]  E. Duysen,et al.  The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency , 2008, Journal of Pharmacology and Experimental Therapeutics.

[194]  M. Lai,et al.  How long can patients with mild or moderate Alzheimer’s dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population‐based study , 2008, European journal of neurology.

[195]  P. Leeson,et al.  The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[196]  A. Padwa,et al.  The Domino Way to Heterocycles. , 2007, Tetrahedron.

[197]  A. Norman.  From Elemental Sulfur , 2007 .

[198]  P. Szymański,et al.  Diagnostics and therapy of Alzheimer's disease. , 2007, Indian journal of experimental biology.

[199]  O. Lockridge,et al.  A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[200]  H. Khan,et al.  Enzyme inhibition activities of teucrium royleanum , 2007 .

[201]  H. Khan,et al.  Enzyme inhibition activities of the extracts from rhizomes of Gloriosa superba Linn (Colchicaceae) , 2007 .

[202]  A. Malik,et al.  Synthesis and antibacterial activity of substituted flavones, 4-thioflavones and 4-iminoflavones. , 2006, Bioorganic & medicinal chemistry.

[203]  Jean-Louis Marty,et al.  Twenty years research in cholinesterase biosensors: from basic research to practical applications. , 2006, Biomolecular engineering.

[204]  Ana Martínez,et al.  Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease , 2006, Expert opinion on investigational drugs.

[205]  N. Greig,et al.  Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent , 2005 .

[206]  N. Strynadka,et al.  β-Lactam antibiotic resistance: a current structural perspective , 2005 .

[207]  A. Yeşilada,et al.  1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: A novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases , 2005, Neuroscience Letters.

[208]  H. Ashton.  The diagnosis and management of benzodiazepine dependence , 2005, Current opinion in psychiatry.

[209]  S. Melov,et al.  Mice transgenic for Alzheimer disease beta-amyloid develop lens cataracts that are rescued by antioxidant treatment. , 2005, Free radical biology & medicine.

[210]  Ian A. Watson,et al.  Selection of heterocycles for drug design. , 2004, Journal of molecular graphics & modelling.

[211]  N. Herrmann,et al.  The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease , 2004, Expert opinion on drug safety.

[212]  R. Desimone,et al.  Privileged structures: applications in drug discovery. , 2004, Combinatorial chemistry & high throughput screening.

[213]  A. Nadin.  The Chemistry of Heterocycles. Structures, Reactions, Synthesis, and Applications. 2nd Edition. By Theophil Eicher and Siegfried Hauptmann. , 2004 .

[214]  J. Dearden,et al.  Design of new cognition enhancers: from computer prediction to synthesis and biological evaluation. , 2004, Journal of medicinal chemistry.

[215]  M. Mesulam,et al.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. , 2003, Archives of neurology.

[216]  N. Greig,et al.  Current drug targets for Alzheimer's disease treatment , 2002 .

[217]  Marsel Mesulam,et al.  Widely Spread Butyrylcholinesterase Can Hydrolyze Acetylcholine in the Normal and Alzheimer Brain , 2002, Neurobiology of Disease.

[218]  I Silman,et al.  A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. , 2001, Biochemistry.

[219]  Xiaoxiang Zhu,et al.  A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase , 2001, Current medical research and opinion.

[220]  Y. Oda,et al.  The distribution of cholinergic neurons in the human central nervous system. , 2000, Histology and histopathology.

[221]  P Taylor,et al.  Specificity and orientation of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases. , 1995, Biochemistry.

[222]  D. Price,et al.  Role of the β‐amyloid protein in Alzheimer's disease , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[223]  P. Watkins,et al.  Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. , 1994, JAMA.

[224]  H. Soreq,et al.  Chorionic villus cDNA library displays expression of butyrylcholinesterase: Putative genetic disposition for ecological danger , 1991, Prenatal diagnosis.

[225]  D. Selkoe.  Amyloid β protein precursor and the pathogenesis of Alzheimer's disease , 1989, Cell.

[226]  O. Lockridge,et al.  Comparison of butyrylcholinesterase and acetylcholinesterase. , 1989, The Biochemical journal.

[227]  O. Lockridge.  Structure of human serum cholinesterase , 1988, BioEssays : news and reviews in molecular, cellular and developmental biology.

[228]  Ryan J. Huxtable,et al.  Biochemistry of Sulfur , 1986, Biochemistry of the Elements.

[229]  S. Zacks,et al.  THE HISTOCHEMICAL LOCALIZATION OF ACETYLCHOLINESTERASE IN THE FINE STRUCTURE OF NEUROMUSCULAR JUNCTIONS OF MOUSE AND HUMAN INTERCOSTAL MUSCLE , 1961, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[230]  M. Saleem,et al.  New synthetic 1,2,4-triazole derivatives: Cholinesterase inhibition and molecular docking studies , 2020 .

[231]  Yun Tang,et al.  Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease. , 2018, European journal of medicinal chemistry.

[232]  A. Hameed,et al.  Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors. , 2017, Bioorganic & medicinal chemistry.

[233]  Zhi-ling Cao,et al.  Synthesis and bioactivity of novel C2-glycosyl triazole derivatives as acetylcholinesterase inhibitors , 2017 .

[234]  S. Moore,et al.  The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design. , 2006, Current pharmaceutical design.

[235]  Alan R. Katritzky,et al.  Comprehensive Heterocyclic Chemistry IV , 1996 .

[236]  T. Maren,et al.  Relatons between structure and biological activity of sulfonamides. , 1976, Annual review of pharmacology and toxicology.

[237]  A. F. Crowther.  Heterocyclic Chemistry , 1964, Nature.